Thomas E. Witzig
Mayo Clinic in Arizona(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, Blood Coagulation and Thrombosis Mechanisms, Acute Myeloid Leukemia Research, Cancer-related Molecular Pathways
Most-Cited Works
- → Phase I/II 90 Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma(2000)234 cited
- → Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma(1994)94 cited
- → Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis(1999)48 cited
- → Thrombosis Related to the Use of L-Asparaginase in Adults with Acute Lymphoblastic Leukemia: a Need to Consider Coagulation Monitoring and Clotting Factor Replacement(1999)31 cited
- → DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas(2024)3 cited
- → Hypomagnesemia in lymphoma patients receiving CAR T therapy correlates with immune dysfunction and decreased survival(2025)
- → Hypomagnesemia in Large B cell Lymphoma patients receiving CAR T cell therapy correlates with immune dysregulation and decreased PFS: results from the ZUMA-1 trial and Mayo Clinic cohort(2024)
- → POSTER: ABCL-1172 High Incidence of Central Nervous System Relapse in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type(2025)